Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on March 26, 2015. The report details a material definitive agreement entered into on the same date regarding the company's equity financing arrangements.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The only financial figures disclosed relate to the equity offering capacity:
- Remaining Offering Capacity: $14,257,211
- Original Offering Capacity: $18,000,000
- Previously Sold Amount: $3,742,789
- Agent Commission: 3.0% of aggregate gross proceeds
Material Changes
On March 26, 2015, the company amended its existing Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. This amendment formalizes the remaining balance available for sale under the agreement. The company may issue and sell shares of common stock through Cantor acting as a sales agent via "at-the-market" offerings or other permitted methods.
Outlook, Risks, and Management Commentary
Management has authorized the sale of shares subject to the terms of the sales agreement, including price, time, or size limits specified by the company. Cantor Fitzgerald is obligated to use commercially reasonable efforts consistent with normal trading practices and applicable regulations to sell shares. The filing includes standard legal disclaimers stating that the report does not constitute an offer to sell securities in any state where such an offer would be unlawful prior to registration.
Key Facts for Investor Verification
- Verify the current market price of Stereotaxis common stock to assess the potential dilution impact of the remaining $14.26 million offering capacity.
- Review the full text of Amendment No. 1 (Exhibit 1.1) for specific terms regarding price limits and termination rights.
- Confirm the company's current cash position and liquidity needs to understand the urgency of utilizing this sales agreement.
- Check subsequent filings to determine if and when shares have been sold under this amended agreement.